Evvy is entering the supplement game.
Tuesday, the vaginal microbiome company, known for its test-to-treatment offerings, is launching its first supplement: Women’s Complete Probiotic, $55 for 30 capsules or $44 a month with a subscription, which supports vaginal, gut and urinary health. Industry sources predict the first run of the launch will sell out this year reaching between $1 million and $2 million in sales.
Since launching in 2021, Evvy has offered an at-home vaginal microbiome test, which looks at over 700 microbes, expert care and access to prescriptions as needed. This launch marks the next step, as the brand aims to provide holistic women’s health solutions.
Evvy reports it will serve 100,000 patients on its platform by the end of the year. To date, the brand has conducted approximately 80,000-plus tests at $159 for a single test or $129 per test with an annual subscription.
“[The Women’s Complete Probiotic] came from us serving over 50,000 women and trying to understand how can we design a first-of-its-kind product, leveraging our unique data set and understanding women,” said Pita Navarro, Evvy cofounder and chief science officer. “Most people are experiencing these symptoms that are interconnected between the gut, the urinary and the vaginal microbiomes.”
Cofounder and chief executive officer Priyanka Jain added: “We were frustrated that we didn’t have better options to offer our patients.…Way too much in women’s health is unexplained and so much of the value that Evvy provides to patients and providers is this idea of eradicating unexplained.”
The Women’s Complete Probiotic combines clinically studied Lactobacillus strains for optimal bacteria and yeast balance and postbiotics and vitamin D and E for gut and immune support. The formula is housed in a patented delayed-release capsule to ensure stability of the probiotics.
The launch is the next step in rounding out Evvy’s offering, particularly as many patients who take the test are recommended an oral probiotic by their care provider, per Jain.
“It gives us a much better oral probiotic than we had ever had access to to really support patients who are trying to restore their vaginal microbiome,” she said. “Once somebody gets to a point where they have a healthy vaginal microbiome, now we have a solution for them that allows them to maintain that over time. We really see it as an extension [of our offering].”
Navarro added this product is ideal for daily support in the midst of “real life factors like hormonal shifts, periods, sexual activity.”
The team predicts it will also be an accessible entry point for new customers who haven’t taken the test yet.
“People might not understand that they have a vaginal microbiome and that they need to test it, and it plays this really important role in their health,” said Jain. “Most people are familiar with the concept of taking a probiotic, so it allows us to reach a wider audience and start that education funnel on why these are such important parts of your body to take care of.”
As the brand expands its offering, Jain said its focus remains on vaginal health and fertility, “whether that means additional types of tests, additional types of treatments, more types of expert providers or support on our platform.”
